PRUCALOPRIDE tablets, for oral use
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2026-01-30
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:58:37
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2107345 | prucalopride 1 MG Oral Tablet | PSN | 1 |
| 2107353 | prucalopride 2 MG Oral Tablet | PSN | 1 |
| 2107345 | prucalopride 1 MG Oral Tablet | SCD | 1 |
| 2107353 | prucalopride 2 MG Oral Tablet | SCD | 1 |
| 2107345 | prucalopride 1 MG (equivalent to prucalopride succinate 1.32 MG) Oral Tablet | SY | 1 |
| 2107353 | prucalopride 2 MG (equivalent to prucalopride succinate 2.64 MG) Oral Tablet | SY | 1 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| PRUCALOPRIDE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20210415 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c75476a7-e531-4d47-9c48-19159bd43a92 | Product name | 2 | 20251024 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1899-3 | prucalopride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 70771-1900-3 | prucalopride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 |
Products#
Every source-derived product name is available through these pages.
- prucalopride
- PRUCALOPRIDE SUCCINATE
- HYPROMELLOSE 2910 (3 MPA.S)
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE 101
- POLYETHYLENE GLYCOL, UNSPECIFIED
- SILICON DIOXIDE
- STARCH, CORN
- TITANIUM DIOXIDE
- TRIACETIN
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1899 | 70771-1899-3 |
| 70771-1900 | 70771-1900-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218056-001 | PRUCALOPRIDE SUCCINATE | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | |
| A218056-002 | PRUCALOPRIDE SUCCINATE | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218056-001 | AB |
| A218056-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218056-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218056-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218056-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218056-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218056-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218056-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218056-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218056-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218056-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2025-08-07 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218056-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2025-08-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218056-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218056-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218056-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218056-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218056-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218056-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218056-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218056-002 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218056-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218056-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| prucalopride | PRUCALOPRIDE | Zydus Lifesciences Limited | da37395d-0a05-4fdc-ab5c-eb7caed62bf1 | 2026-01-30 | 70771-1899-3 70771-1900-3 70771-1900 70771-1899 70771189903 70771190003 051f4f7e-88e8-4706-8183-dbd3f9d42d72 da37395d-0a05-4fdc-ab5c-eb7caed62bf1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

